Cardlytics, Inc.
Close on Oct 19, 2026
- Market cap
- $10.60M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 4, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | After market close | $36.90M | $-1.50 | $-0.81 |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | After market close | $34.30M | $-0.08 | $-0.11 |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 4, 2026 | After market close | $56.10M | $-0.15 | $0.03 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 5, 2025 | After market close | $52.00M | $-1.36 | $-0.07 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 6, 2025 | After market close | $63.20M | $-0.18 | $-0.13 |
| Q1 FY2025 Ended Mar 31, 2025 | May 7, 2025 | After market close | $61.90M | $-0.26 | $-0.21 |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 12, 2025 | After market close | $74.00M | $-0.31 | $0.00 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 6, 2024 | After market close | $67.10M | $-2.90 | $-0.15 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 8, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 29, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on May 7, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDA YoY Changenon-GAAP | Q2 2026 | -$5.70M to -$1.70M | Lowered |
| Adjusted EBITDAnon-GAAP | Q2 2026 | -$2.70M to $1.30M | New |
| Adjusted Contributionnon-GAAP | Q2 2026 | $20.00M to $23.00M | Lowered |
| Billingsnon-GAAP | Q2 2026 | $61.00M to $67.00M | New |
| Adjusted Contribution YoY Changenon-GAAP | Q2 2026 | -36% to -27% growth | Raised |
| Billings YoY Changenon-GAAP | Q2 2026 | -38% to -32% growth | New |
| RevenueGAAP | Q2 2026 | $35.00M to $40.00M | New |
| Revenue YoY ChangeGAAP | Q2 2026 | -40% to -31% growth | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Cardlytics filed with the SEC
Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance
Results of operations · EX-99.1 to Form 8-K
Cardlytics First Quarter 2026 Financial Results Driven By Strong Operational Performance
Results of operations · EX-99.1 to Form 8-K
Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardlytics Announces Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Cardlytics Announces Workforce Reductions As Part Of Organizational Realignment
Exit or restructuring costs · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardlytics Announces Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Cardlytics Announces First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Cardlytics Announces Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Cardlytics Announces Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Cardlytics Announces Second Quarter 2024 Financial Results
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardlytics Appoints Amit Gupta as CEO
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Announces First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Liane Hornsey Appointed to Cardlytics Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardlytics Announces Proposed Convertible Senior Notes Offering
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Cardlytics Prices $150.0 Million Convertible Senior Notes Offering
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.2 to Form 8-K
Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q4 2023 Earnings Presentation March 14, 2024
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results
Material agreement · Results of operations · EX-99.1 to Form 8-K
Cardlytics Appoints Two New Members to its Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardlytics Announces Third Quarter 2023 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q3 2023 Earnings Presentation November 8, 2023
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Appoints Alex Mishurov to its Board of Directors
Material agreement · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Finance Veteran Scott A. Hill appointed to Cardlytics Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardlytics Announces Second Quarter 2023 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q2 2023 Earnings Presentation August 1, 2023
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Appoints New Chief Financial Officer
Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Cardlytics Announces First Quarter 2023 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q1 2023 Earnings Presentation May 4, 2023
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Announces Updated Guidance for First Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Cardlytics Announces Fourth Quarter and Fiscal Year 2022 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q4 2022 Earnings Presentation March 1, 2023
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Appoints Amit Gupta as Chief Operating Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardlytics Announces Third Quarter 2022 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q3 2022 Earnings Presentation November 1, 2022
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Announces Second Quarter 2022 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q2 2022 Earnings Presentation August 2, 2022
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Cardlytics Appoints Karim Temsamani Chief Executive Officer
Results of operations · Executive or director change · EX-99.1 to Form 8-K
Cardlytics Announces First Quarter 2022 Financial Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CARDLYTICS Q1 2022 Earnings Presentation May 2, 2022
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K